Your browser doesn't support javascript.
loading
SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.
Koller, Stephanie; Kendler, Jonatan; Karacs, Jasmine; Wolf, Andrea; Kreuzinger, Caroline; Von Der Decken, Isabel; Mungenast, Felicitas; Mechtcheriakova, Diana; Schreiner, Wolfgang; Gleiss, Andreas; Jäger, Walter; Cacsire Castillo-Tong, Dan; Thalhammer, Theresia.
Affiliation
  • Koller S; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Kendler J; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Karacs J; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Wolf A; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Kreuzinger C; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Von Der Decken I; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Mungenast F; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Mechtcheriakova D; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Schreiner W; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Gleiss A; Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Jäger W; Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Vienna, Austria.
  • Cacsire Castillo-Tong D; Department of Obstetrics and Gynecology, Translational Gynecology Group, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Thalhammer T; Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Front Pharmacol ; 13: 946348, 2022.
Article in En | MEDLINE | ID: mdl-36105223

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Pharmacol Year: 2022 Document type: Article